MedPath
FDA Product

Mometasone Furoate

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Mometasone Furoate

50090-2991

Regulatory Information

50090-2991

ANDA077447

C73584

June 14, 2022

USA

These highlights do not include all the information needed to use MOMETASONE FUROATE CREAM safely and effectively. See full prescribing information for MOMETASONE FUROATE CREAM. MOMETASONE FUROATE cream for topical use Initial U.S. Approval: 1987

HUMAN PRESCRIPTION DRUG LABEL

10

Company Information

830016429

Active Ingredients

PROPYLENE GLYCOL MONOSTEARATE

Code: MZM1I680W0

Class Code: IACT

TITANIUM DIOXIDE

Code: 15FIX9V2JP

Class Code: IACT

ALUMINUM STARCH OCTENYLSUCCINATE

Code: I9PJ0O6294

Class Code: IACT

HEXYLENE GLYCOL

Code: KEH0A3F75J

Class Code: IACT

PHOSPHORIC ACID

Code: E4GA8884NN

Class Code: IACT

STEARYL ALCOHOL

Code: 2KR89I4H1Y

Class Code: IACT

WHITE WAX

Code: 7G1J5DA97F

Class Code: IACT

PETROLATUM

Code: 4T6H12BN9U

Class Code: IACT

WATER

Code: 059QF0KO0R

Class Code: IACT

POLYOXYL 20 CETOSTEARYL ETHER

Code: YRC528SWUY

Class Code: IACT

MOMETASONE FUROATE

Quantity: 1 mg in 1 g

Code: 04201GDN4R

Class Code: ACTIB

Active Moieties

MOMETASONE

Code: 8HR4QJ6DW8

© Copyright 2025. All Rights Reserved by MedPath